Astrana Health Q2 2024 GAAP EPS $0.40 Misses $0.41 Estimate, Sales $486.265M Beat $440.752M Estimate
Portfolio Pulse from Benzinga Newsdesk
Astrana Health (NASDAQ:ASTH) reported Q2 2024 earnings per share (EPS) of $0.40, missing the analyst consensus estimate of $0.41 by 2.44%. However, the company reported quarterly sales of $486.265 million, beating the analyst consensus estimate of $440.752 million by 10.33%. This represents a 39.65% increase over sales of $348.209 million in the same period last year.
August 07, 2024 | 9:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Astrana Health reported Q2 2024 EPS of $0.40, missing estimates by $0.01, but sales of $486.265M beat expectations by 10.33%, showing strong revenue growth.
While the EPS missed estimates slightly, the significant beat in sales and strong year-over-year growth indicate positive business momentum, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100